Aicardi–Goutières syndrome (AGS) is a genetically determined early-onset progressive encephalopathy caused by mutations leading to overexpression of type I interferon (IFN) and resulting in various clinical phenotypes. This evidence concerns the gene IFNA1 and Aicardi-Goutieres syndrome.